Delfi Liquid Biopsy Shows Promise for Reducing Lung Cancer Deaths
BALTIMORE and PALO ALTO, Calif., Aug. 20, 2021 /PRNewswire/ — A novel machine learning based blood testing technology that could help to increase detection of early-stage lung cancer demonstrated promising results in a study published in Nature Communications1. Delfi Diagnostics Inc.’s…
Comments Off on Delfi Liquid Biopsy Shows Promise for Reducing Lung Cancer Deaths